Top compounds associated with response to TIGD5


Feature Type Standardized
Nominal ANOVA
mRNA AZD8055 GDSC1000 pan-cancer AAC 0.015 0.6
mRNA Topotecan CCLE pan-cancer AAC -0.02 0.6
mRNA MS-275 GDSC1000 pan-cancer AAC 0.024 0.6
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.015 0.6
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Doxorubicin GDSC1000 pan-cancer AAC 0.016 0.6
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.6
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.022 0.7
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.023 0.7
Download CSV